Quetiapine treatment in early psychosis: No evidence of cataracts [3]

Schizophrenia Research

Volumn 71, Issue 2-3, 2004, Pages 511-512

  Whitehorn, David ^a   Gallant, Janet ^a   Woodley, Hazel ^a   Rui, Qing ^a   Milliken, Heather ^a   Kopala, Lili ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

QUETIAPINE; RISPERIDONE;

ADULT; CATARACT; CIGARETTE SMOKING; CLINICAL ARTICLE; EXPOSURE; EYE DISEASE; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PSYCHOSIS;

ADULT; ANTIPSYCHOTIC AGENTS; CATARACT; DIBENZOTHIAZEPINES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PSYCHOTIC DISORDERS;

EID: 4944221230     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.02.010     Document Type: Letter

References (4)

1. Laties A. Quetiapine and cataracts. Letter to the editor. The American Journal of Psychiatry. 159(2):2001;322
2. Shahxad S., Suleman M.I., Shahab H., Mazour I., Jaur A., Rudzinskiy P., Lippmann S. Cataract occurrence with antipsychotic drugs. Psychosomatics. 43(5):2002;354-359. (Sep.-Oct.)
3. Stip E., Boisjoly H. Quetiapine: are we overreacting in our concern about cataracts (The Beagle Effect)? Letter to the editor. Canadian Journal of Psychiatry. 44(5):1999;503
4. Valibhai F., Phan N., Still D., True J. Cataracts and quetiapine. Letter to the editor. The American Journal of Psychiatry. 158(6):2001;966